↓ Skip to main content

Chondroitin for osteoarthritis

Overview of attention for article published in this source, January 2015
Altmetric Badge

Mentioned by

3 news outlets
3 blogs
1 policy source
260 tweeters
17 Facebook pages
2 Wikipedia pages
3 Google+ users
3 video uploaders


115 Dimensions

Readers on

442 Mendeley
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chondroitin for osteoarthritis
Published by
John Wiley & Sons, Ltd, January 2015
DOI 10.1002/14651858.cd005614.pub2
Pubmed ID

Singh, Jasvinder A, Noorbaloochi, Shahrzad, MacDonald, Roderick, Maxwell, Lara J


Osteoarthritis, a common joint disorder, is one of the leading causes of disability. Chondroitin has emerged as a new treatment. Previous meta-analyses have shown contradictory results on the efficacy of chondroitin. This, in addition to the publication of more trials, necessitates a systematic review.

Twitter Demographics

The data shown below were collected from the profiles of 260 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 442 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 <1%
Germany 1 <1%
Canada 1 <1%
Brazil 1 <1%
Unknown 438 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 78 18%
Student > Bachelor 66 15%
Researcher 50 11%
Student > Ph. D. Student 39 9%
Other 30 7%
Other 95 21%
Unknown 84 19%
Readers by discipline Count As %
Medicine and Dentistry 173 39%
Nursing and Health Professions 49 11%
Biochemistry, Genetics and Molecular Biology 17 4%
Agricultural and Biological Sciences 17 4%
Pharmacology, Toxicology and Pharmaceutical Science 16 4%
Other 65 15%
Unknown 105 24%